fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
Published 6 years ago • 216 plays • Length 10:25
Download video MP4
Download video MP3
Similar videos
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
10:42
fda approvals of a biosimilar and dtc genetic test, breakthrough designation in mzl, and more
-
9:45
fda approval of a biosimilar, promising data in myeloma and gbm, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
7:22
an overview of biosimilarity
-
1:02
dr. mitri on impact of trastuzumab biosimilar fda approval
-
1:55
dr. hurvitz on the fda approval process for biosimilars
-
7:35
fda approval for abemaciclib
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
5:53
classification and prognosis of glioblastoma
-
1:44
dr. ferris on impact of fda approval of pembrolizumab in patients with head and neck cancer
-
17:25
promising clinical trials for glioblastoma - nicholas butowski, m.d.
-
1:19
azd1775: aiding in the treatment of glioblastomas
-
0:32
the potential of biosimilars in cancer treatment
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
0:58
exploring biosimilars in the field of breast cancer
Clip.africa.com - Privacy-policy